WILMINGTON, Del., June 11, 2020 /PRNewswire/ -- DuPont today
announced it has achieved several milestones in fulfilling its
commitments introduced in August 2019
related to per and polyfluoroalkyl substances (PFAS). These actions
advance the company's plans to achieve its 2030 Sustainability
Goals to make the world safer, healthier and more sustainable.
"We're pleased to have made this progress in delivering on our
promises related to PFAS chemicals as we strive to live our core
values of sustainability and environmental stewardship," said
Alexa Dembek, Chief Technology &
Sustainability Officer, DuPont. "We look forward to sharing further
updates as we continue our progress on these commitments and our
broader 2030 sustainability goals."
To date, DuPont has achieved the following milestones:
- Eliminated the use of long-chain PFAS from our products and
processes, including recently integrated operations, by the end of
2019.
- Eliminated the purchase and storage of PFAS-based firefighting
foams at many of our sites and are on track to eliminate all
PFAS-based firefighting foams at our sites by the end of 2021(where
legally allowed).
- Conducting ongoing remediation at DuPont sites that have a
historic PFAS footprint.
- Providing $6 million of
unrestricted research funding over the next 3 years to the National
Science Foundation (NSF) to fund innovative PFAS remediation
technologies. The NSF recently requested proposals for novel PFAS
research as part of this initiative.
www.nsf.gov/pubs/2020/nsf20090/nsf20090.jsp
- Providing open-source access to technical guidance documents on
how to use DuPont and other manufacturers resin technologies for
PFAS remediation.
www.dupont.com/pfas/remediation-technology-sharing.html
- Enabled access to DuPont's proprietary product stewardship
software to organizations including the Berkeley Center for Green
Chemistry, Beyond Benign, Rutgers and
others. To make this software broadly accessible to others seeking
to guide assessment of chemical alternatives in their operations,
we intend to launch the Chemical Awareness Toolkit at the ACS
24th Annual Green Chemistry and Engineering Conference
on June 15 – 19, 2020.
- Engaging with ERM, an accredited third-party expert and leading
global provider of EHS and sustainability related services, to
review our management of substances of current and emerging concern
to further improve our processes and protocols.
For more information on our actions and to review the full PFAS
commitments, please visit us at www.dupont.com/pfas and follow us
on Twitter @DuPont_news.
About DuPont
DuPont (NYSE: DD) is a global innovation
leader with technology-based materials, ingredients and solutions
that help transform industries and everyday life. Our employees
apply diverse science and expertise to help customers advance their
best ideas and deliver essential innovations in key markets
including electronics, transportation, construction, water, health
and wellness, food, and worker safety. More information can be
found at www.dupont.com/.
Cautionary Statement Regarding Forward Looking
Statements
This communication contains "forward-looking
statements" within the meaning of the federal securities laws,
including Section 27A of the Securities Act of 1933, as amended,
and Section 21E of the Securities Exchange Act of 1934, as amended.
In this context, forward-looking statements often address expected
future business and financial performance and financial condition,
and often contain words such as "expect," "anticipate," "intend,"
"plan," "believe," "seek," "see," "will," "would," "target," and
similar expressions and variations or negatives of these words.
On April 1, 2019, the company
completed the separation of its materials science business into a
separate and independent public company by way of a pro rata
dividend-in-kind of all the then outstanding stock of Dow
Inc. (the "Dow Distribution"). The company completed the
separation of its agriculture business into a separate and
independent public company on June 1,
2019, by way of a pro rata dividend-in-kind of all the then
outstanding stock of Corteva, Inc. (the "Corteva
Distribution").
On December 15, 2019, DuPont and
IFF announced they had entered definitive agreements to combine
DuPont's Nutrition & Biosciences business with IFF in a
transaction that would result in IFF issuing shares to DuPont
shareholders, pending customary closing conditions, other approvals
including regulatory and that of IFF's shareholders.
Forward-looking statements address matters that are, to varying
degrees, uncertain and subject to risks, uncertainties and
assumptions, many of which that are beyond DuPont's control, that
could cause actual results to differ materially from those
expressed in any forward-looking statements. Forward-looking
statements are not guarantees of future results. Some of the
important factors that could cause DuPont's actual results to
differ materially from those projected in any such forward-looking
statements include, but are not limited to: (i) the parties'
ability to meet expectations regarding the timing, completion and
accounting and tax treatments of the proposed transaction with IFF;
changes in relevant tax and other laws, (ii) failure to obtain
necessary regulatory approvals, approval of IFF's shareholders,
anticipated tax treatment or any required financing or to satisfy
any of the other conditions to the proposed transaction with IFF,
(iii) the possibility that unforeseen liabilities, future capital
expenditures, revenues, expenses, earnings, synergies, economic
performance, indebtedness, financial condition, losses, future
prospects, business and management strategies that could impact the
value, timing or pursuit of the proposed transaction with IFF, (iv)
risks and costs and pursuit and/or implementation of the separation
of the N&B Business, including timing anticipated to complete
the separation, any changes to the configuration of businesses
included in the separation if implemented, (v) risks and costs
related to the Dow Distribution and the Corteva Distribution
(together, the "Distributions") including (a) with respect to
achieving all expected benefits from the Distributions; (b) the
incurrence of significant costs in connection with the
Distributions, including costs to service debt incurred by the
Company to establish the relative credit profiles of Corteva, Dow
and DuPont and increased costs related to supply, service and other
arrangements that, prior to the Dow Distribution, were between
entities under the common control of DuPont; (c) indemnification of
certain legacy liabilities of E. I. du Pont de Nemours and Company
("Historical EID") in connection with the Corteva Distribution; and
(d) potential liability arising from fraudulent conveyance and
similar laws in connection with the Distributions; (vi) failure to
effectively manage acquisitions, divestitures, alliances, joint
ventures and other portfolio changes, including meeting conditions
under the Letter Agreement entered in connection with the Corteva
Distribution, related to the transfer of certain levels of assets
and businesses; (vii) uncertainty as to the long-term value of
DuPont common stock; (viii) potential inability or reduced access
to the capital markets or increased cost of borrowings, including
as a result of a credit rating downgrade (ix) risks and
uncertainties related to the novel coronavirus (COVID-19) and the
responses thereto (such as voluntary and in some cases, mandatory
quarantines as well as shut downs and other restrictions on travel
and commercial, social and other activities) on DuPont's
business, results of operations, access to sources of liquidity and
financial condition which depend on highly uncertain and
unpredictable future developments, including, but not limited to,
the duration and spread of the COVID-19 outbreak, its severity, the
actions to contain the virus or treat its impact, and how quickly
and to what extent normal economic and operating conditions resume.
and (x) other risks to DuPont's business, operations and results of
operations including from: failure to develop and market new
products and optimally manage product life cycles; ability, cost
and impact on business operations, including the supply chain, of
responding to changes in market acceptance, rules, regulations and
policies and failure to respond to such changes; outcome of
significant litigation, environmental matters and other commitments
and contingencies; failure to appropriately manage process safety
and product stewardship issues; global economic and capital market
conditions, including the continued availability of capital and
financing, as well as inflation, interest and currency exchange
rates; changes in political conditions, including tariffs, trade
disputes and retaliatory actions; impairment of goodwill or
intangible assets; the availability of and fluctuations in the cost
of energy and raw materials; business or supply disruption,
including in connection with the Distributions; ability to
effectively manage costs as the company's portfolio evolves;
security threats, such as acts of sabotage, terrorism or war,
global health concerns and pandemics, natural disasters and
weather events and patterns which could or could continue to result
in a significant operational event for DuPont, adversely impact
demand or production; ability to discover, develop and protect new
technologies and to protect and enforce DuPont's intellectual
property rights; unpredictability and severity of catastrophic
events, including, but not limited to, acts of terrorism or
outbreak of war or hostilities, as well as management's response to
any of the aforementioned factors. These risks are and will be more
fully discussed in DuPont's current, quarterly and annual reports
and other filings made with the U.S. Securities and Exchange
Commission, in each case, as may be amended from time to time in
future filings with the SEC. While the list of factors presented
here is considered representative, no such list should be
considered a complete statement of all potential risks and
uncertainties. Unlisted factors may present significant additional
obstacles to the realization of forward-looking statements.
Consequences of material differences in results as compared with
those anticipated in the forward-looking statements could include,
among other things, business disruption, operational problems,
financial loss, legal liability to third parties and similar risks,
any of which could have a material adverse effect on DuPont's
consolidated financial condition, results of operations, credit
rating or liquidity. You should not place undue reliance on
forward-looking statements, which speak only as of the date they
are made. DuPont assumes no obligation to publicly provide
revisions or updates to any forward-looking statements whether as a
result of new information, future developments or otherwise, should
circumstances change, except as otherwise required by securities
and other applicable laws. A detailed discussion of some of the
significant risks and uncertainties which may cause results and
events to differ materially from such forward-looking statements is
included in the section titled "Risk Factors" (Part I, Item 1A) of
DuPont's 2019 Annual Report on Form 10-K, Item 8.01 of DuPont's
current report on Form 8-K filed on April 20, 2020 and as updated
by DuPont's subsequent periodic and current reports filed with the
SEC.
6/11/20
DuPont™, the DuPont Oval Logo, and all trademarks and service marks
denoted with ™, ℠ or ® are owned by affiliates of DuPont de
Nemours, Inc. unless otherwise noted.
View original content to download
multimedia:http://www.prnewswire.com/news-releases/dupont-announces-substantial-progress-on-pfas-commitments-301074203.html
SOURCE DuPont